FibroBiologics, Inc. Quarterly Common Stock, Shares Authorized from Q1 2023 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
FibroBiologics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2023 to Q2 2025.
  • FibroBiologics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2025 was 300M shares.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 300M Jun 30, 2025 10-Q 2025-07-31
Q1 2025 100M 0 0% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 100M Dec 31, 2024 10-Q 2025-07-31
Q1 2024 100M +90M +900% Mar 31, 2024 10-Q 2025-07-31
Q1 2023 10M Apr 30, 2023 10-K 2025-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.